Role of vasopressin in mediation of fetal cardiovascular responses to acute hypoxia

Kathleen M. Piacquadio, Robert A. Brace, Cecilia Cheung

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The present study was designed to test the hypothesis that arginine vasopressin mediates the fetal cardiovascular response to acute hypoxia. Chronically catheterized sheep fetuses at 126 to 138 days' gestation were infused with either an arginine vasopressin pressor antagonist (n = 8) or saline solution as control (n = 8). A 30-minute hypoxia was induced by infusion of nitrogen containing 5% carbon dioxide into the maternal trachea. Fetal arterial Po2 decreased 13.1 ± 1.3 (SE) mm Hg from a basal value of 23.8 ± 1.5 mm Hg and there was no significant difference in the degree of hypoxia between the two groups. Fetal arterial and venous pressures increased significantly, whereas the blood volume decreased, but these changes were similar between the control and arginine vasopressin-blocked fetuses. Heart rate fell similarly in both groups during hypoxia by an average of 35 beats/min. At the termination of hypoxia, heart rate in the blocked group rebounded to levels significantly above baseline and remained elevated for 30 minutes, whereas heart rate in the control group returned slowly to basal values. Recovery of arterial pressure, venous pressure, and blood volume were similar in the two groups. Thus it appears that arginine vasopressin may mediate in part the fetal heart rate response to acute hypoxia. However, the blood volume, arterial pressure, and venous pressure responses to hypoxia appear to be induced by factors other than arginine vasopressin.

Original languageEnglish (US)
Pages (from-to)1294-1300
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume163
Issue number4 PART 1
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Vasopressins
Arginine Vasopressin
Venous Pressure
Blood Volume
Arterial Pressure
Heart Rate
Fetus
Fetal Heart Rate
Hypoxia
Trachea
Carbon Dioxide
Sodium Chloride
Sheep
Nitrogen
Mothers
Pregnancy
Control Groups

Keywords

  • arginine vasopressin
  • arterial pressure
  • blood volume
  • Fetus
  • heart rate
  • venous pressure

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Role of vasopressin in mediation of fetal cardiovascular responses to acute hypoxia. / Piacquadio, Kathleen M.; Brace, Robert A.; Cheung, Cecilia.

In: American Journal of Obstetrics and Gynecology, Vol. 163, No. 4 PART 1, 1990, p. 1294-1300.

Research output: Contribution to journalArticle

Piacquadio, Kathleen M. ; Brace, Robert A. ; Cheung, Cecilia. / Role of vasopressin in mediation of fetal cardiovascular responses to acute hypoxia. In: American Journal of Obstetrics and Gynecology. 1990 ; Vol. 163, No. 4 PART 1. pp. 1294-1300.
@article{5db70c8d5b204885b755cf91bb5a7bee,
title = "Role of vasopressin in mediation of fetal cardiovascular responses to acute hypoxia",
abstract = "The present study was designed to test the hypothesis that arginine vasopressin mediates the fetal cardiovascular response to acute hypoxia. Chronically catheterized sheep fetuses at 126 to 138 days' gestation were infused with either an arginine vasopressin pressor antagonist (n = 8) or saline solution as control (n = 8). A 30-minute hypoxia was induced by infusion of nitrogen containing 5{\%} carbon dioxide into the maternal trachea. Fetal arterial Po2 decreased 13.1 ± 1.3 (SE) mm Hg from a basal value of 23.8 ± 1.5 mm Hg and there was no significant difference in the degree of hypoxia between the two groups. Fetal arterial and venous pressures increased significantly, whereas the blood volume decreased, but these changes were similar between the control and arginine vasopressin-blocked fetuses. Heart rate fell similarly in both groups during hypoxia by an average of 35 beats/min. At the termination of hypoxia, heart rate in the blocked group rebounded to levels significantly above baseline and remained elevated for 30 minutes, whereas heart rate in the control group returned slowly to basal values. Recovery of arterial pressure, venous pressure, and blood volume were similar in the two groups. Thus it appears that arginine vasopressin may mediate in part the fetal heart rate response to acute hypoxia. However, the blood volume, arterial pressure, and venous pressure responses to hypoxia appear to be induced by factors other than arginine vasopressin.",
keywords = "arginine vasopressin, arterial pressure, blood volume, Fetus, heart rate, venous pressure",
author = "Piacquadio, {Kathleen M.} and Brace, {Robert A.} and Cecilia Cheung",
year = "1990",
doi = "10.1016/0002-9378(90)90709-G",
language = "English (US)",
volume = "163",
pages = "1294--1300",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4 PART 1",

}

TY - JOUR

T1 - Role of vasopressin in mediation of fetal cardiovascular responses to acute hypoxia

AU - Piacquadio, Kathleen M.

AU - Brace, Robert A.

AU - Cheung, Cecilia

PY - 1990

Y1 - 1990

N2 - The present study was designed to test the hypothesis that arginine vasopressin mediates the fetal cardiovascular response to acute hypoxia. Chronically catheterized sheep fetuses at 126 to 138 days' gestation were infused with either an arginine vasopressin pressor antagonist (n = 8) or saline solution as control (n = 8). A 30-minute hypoxia was induced by infusion of nitrogen containing 5% carbon dioxide into the maternal trachea. Fetal arterial Po2 decreased 13.1 ± 1.3 (SE) mm Hg from a basal value of 23.8 ± 1.5 mm Hg and there was no significant difference in the degree of hypoxia between the two groups. Fetal arterial and venous pressures increased significantly, whereas the blood volume decreased, but these changes were similar between the control and arginine vasopressin-blocked fetuses. Heart rate fell similarly in both groups during hypoxia by an average of 35 beats/min. At the termination of hypoxia, heart rate in the blocked group rebounded to levels significantly above baseline and remained elevated for 30 minutes, whereas heart rate in the control group returned slowly to basal values. Recovery of arterial pressure, venous pressure, and blood volume were similar in the two groups. Thus it appears that arginine vasopressin may mediate in part the fetal heart rate response to acute hypoxia. However, the blood volume, arterial pressure, and venous pressure responses to hypoxia appear to be induced by factors other than arginine vasopressin.

AB - The present study was designed to test the hypothesis that arginine vasopressin mediates the fetal cardiovascular response to acute hypoxia. Chronically catheterized sheep fetuses at 126 to 138 days' gestation were infused with either an arginine vasopressin pressor antagonist (n = 8) or saline solution as control (n = 8). A 30-minute hypoxia was induced by infusion of nitrogen containing 5% carbon dioxide into the maternal trachea. Fetal arterial Po2 decreased 13.1 ± 1.3 (SE) mm Hg from a basal value of 23.8 ± 1.5 mm Hg and there was no significant difference in the degree of hypoxia between the two groups. Fetal arterial and venous pressures increased significantly, whereas the blood volume decreased, but these changes were similar between the control and arginine vasopressin-blocked fetuses. Heart rate fell similarly in both groups during hypoxia by an average of 35 beats/min. At the termination of hypoxia, heart rate in the blocked group rebounded to levels significantly above baseline and remained elevated for 30 minutes, whereas heart rate in the control group returned slowly to basal values. Recovery of arterial pressure, venous pressure, and blood volume were similar in the two groups. Thus it appears that arginine vasopressin may mediate in part the fetal heart rate response to acute hypoxia. However, the blood volume, arterial pressure, and venous pressure responses to hypoxia appear to be induced by factors other than arginine vasopressin.

KW - arginine vasopressin

KW - arterial pressure

KW - blood volume

KW - Fetus

KW - heart rate

KW - venous pressure

UR - http://www.scopus.com/inward/record.url?scp=0025173576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025173576&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(90)90709-G

DO - 10.1016/0002-9378(90)90709-G

M3 - Article

VL - 163

SP - 1294

EP - 1300

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4 PART 1

ER -